Literature DB >> 33365370

Multiple breath washout test data for healthy controls.

Lauren M Zell-Baran1, Silpa D Krefft1,2,3, Camille M Moore4,5, Jenna Wolff1, Richard Meehan1,3, Cecile S Rose1,3.   

Abstract

This article includes pulmonary function data collected via multiple breath nitrogen washout for 103 healthy U.S. adults recruited at National Jewish Health in Denver, Colorado. Testing was performed by certified technicians and reviewed by expert pulmonologists for quality and consistency. Data were collected from a diverse population that included 52 males and 51 females with an average age of 39 years (range 20-77 years). Participants were of non-Hispanic White (85%), African-American/Black (6%), Hispanic (4%), more than one race (4%) or American Indian/Alaskan Native (1%) race/ethnicity. The majority were never smokers (85%), but 12% were former smokers and 3% were current smokers. Height, weight, and body mass index (BMI) were collected in addition to multiple breath washout (MBW) test parameters such as the lung clearance index (LCI) score.
© 2020 The Authors.

Entities:  

Keywords:  Healthy control; Lung clearance index; Lung function; Multiple breath washout

Year:  2020        PMID: 33365370      PMCID: PMC7749374          DOI: 10.1016/j.dib.2020.106641

Source DB:  PubMed          Journal:  Data Brief        ISSN: 2352-3409


Specifications Table

Value of the Data

Published normative data for healthy adults using multiple breath washout is limited and has not included a heterogeneous population. Investigators working with adult lung disease patients will benefit from access to this data as a reference for healthy multiple breath washout values. Others can build upon this data to create an even more robust set of normative data to be used consistently across study sites.

Data Description

Histograms of LCI scores among never-smoking controls with BMI values <30 (n = 70) are presented in Fig. A1. The upper limit of normal (ULN) was calculated as the mean + 1.96*standard deviation [1]. Among males (n = 32), the ULN was 8.71 and among females, the ULN was 8.17. We categorized BMI as normal weight (BMI<25), overweight (BMI25–29.9), or obese (BMI>30) [2] in Fig. A2 to display the relationship between BMI and MBW parameters.
Fig. A1

Distribution of lung clearance index scores among never smoking controls with body mass index <30 by sex.

Fig. A2

Distribution of multiple breath washout parameters by body mass index category

Distribution of lung clearance index scores among never smoking controls with body mass index <30 by sex. Distribution of multiple breath washout parameters by body mass index category Raw Data: Raw multiple breath washout data and relevant demographic characteristics are included on the attached Excel file for download. Data from all trials are not provided, rather results are the average of all acceptable trials. A description of the variables in the raw dataset is presented in Table A1.
Table A1

Description of variables in raw dataset.

Variable NameDescriptionUnits or Levels
sexSexMale, Female
raceRaceAfrican-American/Black, American Indian/Alaska Native, More than once race, White
ethnicityEthnicityHispanic, Non-Hispanic White, Other
ageAgeyears
height_cmHeightcm
weight_kgWeightkg
bmiBody Mass Indexkg/m2
smoking_statusSmoking statusNever, Former, Current
packyearsSmoking pack-yearspack-years
frcFunctional Residual Capacity (FRC)L
lci_scoreLung Clearance Index Score (2.5%)unitless
lci_5_normLung Clearance Index Score (5.0%)unitless
m1_m0First Moment of washout curve (M1/M0)unitless
m2_m0Second Moment of washout curve (M2/M0)unitless
scondvtScond * Tidal Volume (Scond*VT)unitless
sacinvtSacin * Tidal Volume (Sacin*VT)unitless
rqRespiratory Quotient (RQ)unitless
vt_frcTidal volume/FRC (VT/FRC)unitless
vtmean_mlMean VTmL
vd_co2VdCO2mL
cevCumulative Expired Volume (CEV)L
Description of variables in raw dataset.

Experimental Design, Materials and Methods

Participants were recruited at National Jewish Health in Denver, Colorado between March 2015 and March 2020 as part of a larger study aimed at understanding deployment-related lung diseases. Participants were screened for both previously diagnosed chronic respiratory disease and for acute respiratory illness in the four weeks preceding scheduled testing. All testing was completed in a clinical research testing room with medical air and oxygen hook ups. To confirm healthy control status, pre-bronchodilator spirometry was performed 15 min before multiple breath washout testing using American Thoracic Society Guidelines [4,5]. Participants with forced vital capacity percent predicted (FVCPP), forced expiratory volume in one second percent predicted (FEV1PP), or FEV1/FVC ratio below the lower limits of normal (LLN) based on published reference values were excluded from MBW testing. [6] 25 of the subjects were from the pilot study and did not have spirometry, which was added to data collection after the pilot. MBW testing was performed using the Eco Medics AG Exhalyzer D system and Spiroware software. On each day of testing, environmental settings including temperature and pressure were adjusted, flow and gas channel calibrations were performed, and signal synchronizations were performed. Adult size filters and mouthpieces were used with dead space reducer set 3 (DSR 3). Spirettes and nafion tubes were replaced at recommended intervals. During testing, subjects were seated upright, wore a nose clip, and were advised to perform relaxed breathing. Subjects began normal breathing on room air to establish tidal volume. The washout phase used 100% oxygen and concluded when subjects’ nitrogen concentrations were below 1/40 or 2.5% of their initial concentration. Results presented are the average of at least two acceptable trials. Trials were deemed unacceptable if 1) the tracer gas did not re-equilibrate between trials, 2) there was clear evidence of a leak, 3) the breathing pattern was erratic, or 4) the trial did not meet end of test criteria described by Jensen et al. [7].

Ethics Statement

Study participants agreed to complete testing with written informed consent under studies HS-2851 and HS-2985 approved by the National Jewish Health Institutional Review Board.

CRediT Author Statement

Lauren Zell-Baran: Formal Analysis, Investigation, Writing – Original Draft, Visualization. Silpa Krefft: Conceptualization, Validation, Writing – Review & Editing. Camille Moore: Methodology, Formal Analysis, Writing – Review & Editing. Jenna Wolff: Investigation, Project Administration, Writing – Review & Editing. Richard Meehan: Conceptualization, Writing – Review & Editing. Cecile Rose: Conceptualization, Resources, Writing – Original Draft, Supervision, Funding.

Declaration of Competing Interest

Cecile Rose receives research grant funding from the U.S. Department of Defense as part of a large multi-site, multi-investigator study on mechanisms of lung epithelial injury. Silpa Krefft is employed by the U.S. Department of Veterans Affairs (DVA) and receives research grant funding from the DVA. Both Drs. Rose and Krefft have participated in medicolegal depositions to provide expert testimony on patients for whom they have rendered medical opinions; however, they have received no personal income or compensation for these medicolegal efforts, all of which have been reimbursed to National Jewish Health.
SubjectPulmonary and Respiratory Medicine
Specific subject areaPulmonary physiology measurements using multiple breath nitrogen washout testing
Type of dataTableFigure
How data were acquiredInstrument: Eco Medics AG Exhalyzer D system with adult setup and oxygen tracer gasSoftware: Spiroware by Eco Medics AG
Data formatRaw
Parameters for data collectionSexRaceEthnicityAge (years)Height (cm)Weight (kg)Smoking statusSmoking pack-yearsFunctional Residual Capacity (FRC) (L)Lung Clearance Index Score (2.5%)Lung Clearance Index Score (5.0%)First Moment of washout curve (M1/M0)Second Moment of washout curve (M2/M0)Scond * Tidal Volume (Scond*VT)Sacin * Tidal Volume (Sacin*VT)Respiratory Quotient (RQ)Tidal volume/FRC (VT/FRC)Mean VT (mL)VdCO2 (mL)Cumulative Expired Volume (CEV) (L)
Description of data collectionHealthy control status was assessed based on self-reported respiratory symptoms and diagnoses. Control subjects were screened via pre-bronchodilator spirometry before undergoing multiple breath washout testing, and excluded if they reported symptoms, lung diagnoses or had abnormal spirometry.Testing was performed during a single study visit by trained technicians who were certified by SickKids Hospital in Toronto, Canada for MBW and by the National Institute for Occupational Safety and Health for spirometry.
Data source locationInstitution: National Jewish HealthCity/Town/Region: Denver, COCountry: United States of America
Data accessibilityWith the article (see “Control_MBW_data.xlsx”).
Related research articleZell-Baran, L., Krefft, S.D., Moore, C.M., Wolff, J., Meehan, R., Rose, C.S. Multiple Breath Washout: A Noninvasive Tool for Identifying Lung Disease in Symptomatic Military Deployers. Respir. Med. In Press. [3]
  6 in total

1.  Lung Clearance Index in Adults and Children With Cystic Fibrosis.

Authors:  Katherine O'Neill; Michael M Tunney; Elinor Johnston; Stephen Rowan; Damian G Downey; Jacqueline Rendall; Alastair Reid; Ian Bradbury; J Stuart Elborn; Judy M Bradley
Journal:  Chest       Date:  2016-07-06       Impact factor: 9.410

2.  Standardisation of the single-breath determination of carbon monoxide uptake in the lung.

Authors:  N Macintyre; R O Crapo; G Viegi; D C Johnson; C P M van der Grinten; V Brusasco; F Burgos; R Casaburi; A Coates; P Enright; P Gustafsson; J Hankinson; R Jensen; R McKay; M R Miller; D Navajas; O F Pedersen; R Pellegrino; J Wanger
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

3.  Standardisation of spirometry.

Authors:  M R Miller; J Hankinson; V Brusasco; F Burgos; R Casaburi; A Coates; R Crapo; P Enright; C P M van der Grinten; P Gustafsson; R Jensen; D C Johnson; N MacIntyre; R McKay; D Navajas; O F Pedersen; R Pellegrino; G Viegi; J Wanger
Journal:  Eur Respir J       Date:  2005-08       Impact factor: 16.671

4.  Spirometric reference values from a sample of the general U.S. population.

Authors:  J L Hankinson; J R Odencrantz; K B Fedan
Journal:  Am J Respir Crit Care Med       Date:  1999-01       Impact factor: 21.405

5.  Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.

Authors:  Lauren M Zell-Baran; Silpa D Krefft; Camille M Moore; Jenna Wolff; Richard Meehan; Cecile S Rose
Journal:  Respir Med       Date:  2020-12-05       Impact factor: 3.415

6.  A Systematic Approach to Multiple Breath Nitrogen Washout Test Quality.

Authors:  Renee Jensen; Sanja Stanojevic; Michelle Klingel; Maria Ester Pizarro; Graham L Hall; Kathryn Ramsey; Rachel Foong; Clare Saunders; Paul D Robinson; Hailey Webster; Kate Hardaker; Mica Kane; Felix Ratjen
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

  6 in total
  2 in total

1.  Multiple breath washout: A noninvasive tool for identifying lung disease in symptomatic military deployers.

Authors:  Lauren M Zell-Baran; Silpa D Krefft; Camille M Moore; Jenna Wolff; Richard Meehan; Cecile S Rose
Journal:  Respir Med       Date:  2020-12-05       Impact factor: 3.415

2.  Multiple Breath Washout for Early Assessment of Pulmonary Complications in Patients With Primary Antibody Deficiencies: An Observational Study in Pediatric Age.

Authors:  Teresa Secchi; Lucia Augusta Baselli; Maria Chiara Russo; Irene Maria Borzani; Federica Carta; Maria Amalia Lopopolo; Michaela Foà; Adriano La Vecchia; Carlo Agostoni; Massimo Agosti; Rosa Maria Dellepiane
Journal:  Front Pediatr       Date:  2022-05-17       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.